Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary Angiopathy in Severe COVID-19: Physiological Conclusions Derived from Ventilatory Ratio?

American journal of respiratory and critical care medicine·2020
Same author

Biomarkers in the ICU: less is more? No.

Intensive care medicine·2020
Same author

Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020).

European respiratory review : an official journal of the European Respiratory Society·2020
Same author

Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome.

EBioMedicine·2020
Same author

Validation of a Prediction Score for Drug-Resistant Microorganisms in Community-acquired Pneumonia.

Annals of the American Thoracic Society·2020
Same author

Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience.

Respiratory medicine·2020

Related Experiment Video

Updated: Jun 16, 2026

Non-Intubated Video-Assisted Thoracoscopic Surgery
05:39

Non-Intubated Video-Assisted Thoracoscopic Surgery

Published on: May 26, 2023

Do guidelines change outcomes in ventilator-associated pneumonia?

Gianluigi Li Bassi1, Miguel Ferrer, Lina M Saucedo

  • 1Department of Pneumology and Critical Care, Hospital Clinic, Thorax Institute, Barcelona, Spain.

Current Opinion in Infectious Diseases
|February 6, 2010
PubMed
Summary

Implementing ventilator-associated pneumonia (VAP) guidelines improves patient outcomes. Adapting guidelines to local microbiology and accurately predicting pathogens are crucial for effective empirical antibiotic therapy and survival.

Related Experiment Videos

Last Updated: Jun 16, 2026

Non-Intubated Video-Assisted Thoracoscopic Surgery
05:39

Non-Intubated Video-Assisted Thoracoscopic Surgery

Published on: May 26, 2023

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Ventilator-associated pneumonia (VAP) is a significant concern in intensive care units.
  • Effective management and treatment guidelines aim to improve patient outcomes and reduce mortality.
  • Challenges exist in translating guidelines into consistent clinical practice.

Purpose of the Study:

  • To summarize the impact of implementing current and past VAP management guidelines on intensive care patient outcomes.
  • To focus on VAP etiology, pathogen prediction, appropriate empiric antibiotic therapy, and mortality.
  • To evaluate the effectiveness of established VAP treatment protocols.

Main Methods:

  • Review of existing studies on VAP guideline implementation.
  • Analysis of data concerning VAP etiology and pathogen identification.
  • Assessment of the relationship between timely antibiotic therapy and patient survival.

Main Results:

  • Timely and appropriate antibiotic therapy in suspected VAP cases is linked to improved survival rates.
  • Guideline implementation, when achieved through education and local protocol adaptation, is associated with better patient outcomes.
  • Current guidelines require further validation for accurately predicting VAP etiology, especially for multidrug-resistant pathogens.

Conclusions:

  • Successful implementation of VAP guidelines can lead to improved patient outcomes.
  • Guidelines must be tailored to local microbial patterns and enhance the prediction of VAP pathogens.
  • Accurate pathogen prediction is essential for guiding appropriate empirical antimicrobial therapy in VAP management.